Barclays
IMNN icon

Barclays’s Imunon IMNN Stock Holding History

Barclays’s Portfolio IMNN Stock Details IMNN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Hold
0
– -$1K – 6270
2015
Q4 		– Hold
0
– – – 5825
2015
Q1 		– Sell
-8
Closed -$45K – 7158
2014
Q4 		$45K Sell
8
-1
-11% -$6.94K ﹤0.01% 5803
2014
Q3 		$48K Sell
9
-8
-47% -$69.7K ﹤0.01% 5911
2014
Q2 		$138K Sell
17
-6
-26% -$53.6K ﹤0.01% 5172
2014
Q1 		$189K Buy
23
+8
+53% +$83.3K ﹤0.01% 4841
2013
Q4 		$122K Buy
15
+9
+150% +$108K ﹤0.01% 5462
2013
Q3 		$80K Hold
6
– – ﹤0.01% 5794
2013
Q2 		$78K Buy
+6
New +$83.4K ﹤0.01% 5993

Other funds holding IMNN

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Nvest Financial
Nvest Financial Portsmouth, New Hampshire $329M AUM 20.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $73.3B AUM 63.67% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $83.6B AUM 19.78% 1-Year Est. Return
Game Plan Financial Advisors
Game Plan Financial Advisors Westlake, Ohio $264M AUM 21.06% 1-Year Est. Return
GK Wealth Management
GK Wealth Management Reno, Nevada $178M AUM 41.48% 1-Year Est. Return

Barclays's IMNN Position: Q3 2026 in Review

Barclays sold out of Imunon (IMNN) in Q3 2026, closing a stake of 194 shares — an estimated $345 sold.

Barclays first reported a position in IMNN in Q2 2013 and held it in 14 quarters. The position peaked at $59K in Q2 2014. 11 funds tracked by Wall St. Rank hold IMNN as of Q3 2026.

  • Barclays reported no remaining Imunon position as of Q3 2026 after selling out during the quarter.
  • Barclays sold 194 Imunon shares in Q3 2026, an estimated $345.
  • Barclays first reported a position in Imunon in Q2 2013 and held it in 14 quarters.
  • Barclays's Imunon position peaked at $59K in Q2 2014.
  • 11 funds tracked by Wall St. Rank held Imunon as of Q3 2026.

Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.